InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Sinclair Andrew, Director. Director active across 3 companies, notably Adicet Bio, Inc.. In total, 8 disclosures have been published. Total volume traded: €24.8m. The latest transaction was disclosed on 1 July 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
€69m1,314,127 shares@ €52.492591.0% of flow
Common Stock, $0.001 par value
SEC:0001493152-22-018397:0·
7,720,000 shares
Common Stock
SEC:0000905718-22-000521:0·
Ideal exit: 24 Dec 2022 (T+270)
€3m287,471 shares@ €11.8417100.0% of flow
Common Stock, $0.001 par value
SEC:0000905718-22-000178·
€3m287,471 shares@ €11.84174.5% of flow
Common Stock, $0.001 par value
SEC:0000905718-22-000178:0·
€6m500,000 shares@ €12.41527.69% mcap50.0% of flow
Common Stock
SEC:0000905718-21-001591·
Ideal exit: 4 Sept 2022 (T+270)
€6m500,000 shares@ €12.41527.69% mcap25.0% of flow
Common Stock
SEC:0000905718-21-001591:0·
Ideal exit: 4 Sept 2022 (T+270)
€6m500,000 shares@ €12.41527.69% mcap50.0% of flow
Common Stock
SEC:0000905718-21-001587·
Ideal exit: 4 Sept 2022 (T+270)
€6m500,000 shares@ €12.41527.69% mcap25.0% of flow
Common Stock
SEC:0000905718-21-001587:0·
Ideal exit: 4 Sept 2022 (T+270)
8 of 8 declarations
About Sinclair Andrew
Andrew Sinclair is a Board Member at Adicet Bio, Inc., Sierra Oncology, Inc., and Soleno Therapeutics Inc. He contributes to corporate governance and strategic decision-making for these companies.
